|
Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis |
Brunner-La Rocca H P, Kaiser C, Bernheim A, Zellweger M J, Jeger R, Buser P T, Osswald S, Pfisterer M |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Brunner-La Rocca H P, Kaiser C, Bernheim A, Zellweger M J, Jeger R, Buser P T, Osswald S, Pfisterer M. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis. Lancet 2007; 370: 1552-1559 Indexing Status Subject indexing assigned by NLM MeSH Aged; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents /administration & Coronary Disease /economics /prevention & Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Paclitaxel /administration & Quality-Adjusted Life Years; Risk Factors; Sirolimus /administration & Stents /adverse effects /economics; control /therapy; dosage /adverse effects /economics; dosage /adverse effects /economics; dosage /adverse effects /economics AccessionNumber 22007008290 Date bibliographic record published 29/08/2007 |
|
|
|